Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | Echocardiography | Case report

Syphilis-associated septic cardiomyopathy: case report and review of the literature

Authors: Shiqi Guo, Qiang Guo

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

Septic cardiomyopathy has been observed in association with influenza, indicating that not only bacteria but also other infective agents can cause this condition. There has been no systematic study as to whether Treponema pallidum infection induces septic cardiomyopathy, and we are the first to report this possibility.

Case presentation

We report two cases of a 48-year-old man and a 57-year-old man who were diagnosed with syphilis-related septic cardiomyopathy. The diagnosis of cardiomyopathy was made based on elevation of cardiogenic markers and decrease in ejection fraction evaluated by echocardiography. Screen for infective pathogens was negative except for syphilis, which supported our diagnosis. The two patients recovered following effective anti-syphilis treatment and advanced life support technology. Syphilis serology became negative after treatment.

Conclusion

Syphilis has the potential to cause septic cardiomyopathy. Clinicians should consider Treponema pallidum in cases of septic cardiomyopathy with unknown pathogens. However, the specific pathophysiological mechanism of syphilis-associated septic cardiomyopathy has not been elucidated, and more specific studies are needed.
Literature
1.
go back to reference Beesley SJ, Weber G, Sarge T, Nikravan S, Grissom CK, Lanspa MJ, Shahul S, Brown SM. Septic cardiomyopathy. Crit Care Med. 2018;46(4):625–34.CrossRef Beesley SJ, Weber G, Sarge T, Nikravan S, Grissom CK, Lanspa MJ, Shahul S, Brown SM. Septic cardiomyopathy. Crit Care Med. 2018;46(4):625–34.CrossRef
2.
go back to reference Huang M, Cai S, Su J. The Pathogenesis of Sepsis and Potential Therapeutic Targets. Int J Mol Sci. 2019;20(21):5376. Huang M, Cai S, Su J. The Pathogenesis of Sepsis and Potential Therapeutic Targets. Int J Mol Sci. 2019;20(21):5376.
3.
go back to reference Ehrman RR, Sullivan AN, Favot MJ, Sherwin RL, Reynolds CA, Abidov A, Levy PD. Pathophysiology, echocardiographic evaluation, biomarker findings, and prognostic implications of septic cardiomyopathy: a review of the literature. Crit Care. 2018;22(1):112.CrossRef Ehrman RR, Sullivan AN, Favot MJ, Sherwin RL, Reynolds CA, Abidov A, Levy PD. Pathophysiology, echocardiographic evaluation, biomarker findings, and prognostic implications of septic cardiomyopathy: a review of the literature. Crit Care. 2018;22(1):112.CrossRef
4.
go back to reference Fujioka M, Suzuki K, Iwashita Y, Imanaka-Yoshida K, Ito M, Katayama N, Imai H. Influenza-associated septic shock accompanied by septic cardiomyopathy that developed in summer and mimicked fulminant myocarditis. Acute Med Surg. 2019;6(2):192–6.CrossRef Fujioka M, Suzuki K, Iwashita Y, Imanaka-Yoshida K, Ito M, Katayama N, Imai H. Influenza-associated septic shock accompanied by septic cardiomyopathy that developed in summer and mimicked fulminant myocarditis. Acute Med Surg. 2019;6(2):192–6.CrossRef
5.
go back to reference Tsolaki V, Makris D, Mantzarlis K, Zakynthinos E: Sepsis-induced cardiomyopathy: oxidative implications in the initiation and resolution of the damage. Oxidative Med Cell Longev 2017, 2017:7393525. Tsolaki V, Makris D, Mantzarlis K, Zakynthinos E: Sepsis-induced cardiomyopathy: oxidative implications in the initiation and resolution of the damage. Oxidative Med Cell Longev 2017, 2017:7393525.
6.
go back to reference Tsimis ME, Sheffield JS. Update on syphilis and pregnancy. Birth Defects Res. 2017;109(5):347–52.CrossRef Tsimis ME, Sheffield JS. Update on syphilis and pregnancy. Birth Defects Res. 2017;109(5):347–52.CrossRef
7.
go back to reference Fernandes B, Santos A, Carvalho L. Syphilitic Aortitis diagnosis in clinical setting. Rev Port Cir Cardiotorac Vasc. 2017;24(3–4):166.PubMed Fernandes B, Santos A, Carvalho L. Syphilitic Aortitis diagnosis in clinical setting. Rev Port Cir Cardiotorac Vasc. 2017;24(3–4):166.PubMed
8.
9.
go back to reference Drago FMG, Rebora A, Parodi A. Syphilitic aortitis and its complications in the modern era. Gital Dermatol Venereol. 2018;153:698–706. Drago FMG, Rebora A, Parodi A. Syphilitic aortitis and its complications in the modern era. Gital Dermatol Venereol. 2018;153:698–706.
10.
go back to reference Krivosheev AB, Nadeev AP, Kuimov AD, Travin MA. Cardiovascular syphilis current state of the problem and analysis of own observations. Ter Arkh. 2019;91(11):81–5.PubMed Krivosheev AB, Nadeev AP, Kuimov AD, Travin MA. Cardiovascular syphilis current state of the problem and analysis of own observations. Ter Arkh. 2019;91(11):81–5.PubMed
11.
go back to reference Hebert-Schuster M, Borderie D, Grange PA, Lemarechal H, Kavian-Tessler N, Batteux F, Dupin N. Oxidative stress markers are increased since early stages of infection in syphilitic patients. Arch Dermatol Res. 2012;304(9):689–97.CrossRef Hebert-Schuster M, Borderie D, Grange PA, Lemarechal H, Kavian-Tessler N, Batteux F, Dupin N. Oxidative stress markers are increased since early stages of infection in syphilitic patients. Arch Dermatol Res. 2012;304(9):689–97.CrossRef
Metadata
Title
Syphilis-associated septic cardiomyopathy: case report and review of the literature
Authors
Shiqi Guo
Qiang Guo
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05722-z

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.